Through the JAK/STAT3 pathway, IL-6 promotes B7-H4 expression in gliomas, whereas STAT3 modulates B7-H4 transcription by enhancing the B7-H4 promoter [111]. The gene discussed is VTCN1; the disease is central nervous system cancer.